Annals of Neurology · 2012 · 520 citations · 54 references
CLB/LN pathology is the most significant correlate of dementia in PD. Additionally, APOE4 genotype may independently influence the risk of dementia in PD. AD pathology was abundant in a subset of patients, and may modify the clinical phenotype. Thus, therapies that target α-synuclein, tau, or amyloid β could potentially improve cognitive performance in PD.
54
Staging of brain pathology related to sporadic Parkinson’s disease
Heiko Braak, Kelly Del Tredici, Udo Rüb et al. · Neurobiology of Aging · 2002 · 10.5K citations
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Suzanne S. Mirra, Albert Heyman, Daniel W. McKeel et al. · Neurology · 1991 · 5K citations
α-Synuclein Locus Triplication Causes Parkinson's Disease
Andrew Singleton · Science · 2003 · 4.3K citations
Mitophagy, Farnesyltransferase Inhibition, Social Sciences +16
Thomas J. Montine, Creighton H. Phelps, Thomas G. Beach et al. · Acta Neuropathologica · 2011 · 2.8K citations · Full text
Prevalence and Characteristics of Dementia in Parkinson Disease
Dag Aarsland, Kjeld Andersen, Jan Larsen et al. · Archives of Neurology · 2003 · 1.4K citations